Trial Profile
Contrast-enhanced Ultrasound for Complex Kidney Lesion Diagnosis in Patients With CKD (CEUS CKD)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 27 Sep 2019
Price :
$35
*
At a glance
- Drugs Perflutren (Primary)
- Indications Renal failure
- Focus Diagnostic use
- Acronyms CEUS-CKD
- 26 Oct 2018 Status changed from active, no longer recruiting to completed.
- 31 Jul 2018 Planned End Date changed from 1 Jun 2018 to 1 Aug 2018.
- 31 Jul 2018 Planned primary completion date changed from 1 Jun 2018 to 1 Aug 2018.